240 related articles for article (PubMed ID: 9013738)
41. Intraventricular insulin reduces food intake and body weight of lean but not obese Zucker rats.
Ikeda H; West DB; Pustek JJ; Figlewicz DP; Greenwood MR; Porte D; Woods SC
Appetite; 1986 Dec; 7(4):381-6. PubMed ID: 3539015
[TBL] [Abstract][Full Text] [Related]
42. Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats.
Davis HR; Mullins DE; Pines JM; Hoos LM; France CF; Compton DS; Graziano MP; Sybertz EJ; Strader CD; Van Heek M
Obes Res; 1998 Mar; 6(2):147-56. PubMed ID: 9545022
[TBL] [Abstract][Full Text] [Related]
43. Multiple cycles of repeated treatments with a Phaseolus vulgaris dry extract reduce food intake and body weight in obese rats.
Carai MA; Fantini N; Loi B; Colombo G; Gessa GL; Riva A; Bombardelli E; Morazzoni P
Br J Nutr; 2011 Sep; 106(5):762-8. PubMed ID: 21535904
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of chronic opioid receptor antagonist effects upon weight and intake measures in lean and obese Zucker rats.
Cole JL; Berman N; Bodnar RJ
Peptides; 1997; 18(8):1201-7. PubMed ID: 9396062
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of food response to intracerebroventricular injection of leptin is attenuated in rats with diet-induced obesity.
Widdowson PS; Upton R; Buckingham R; Arch J; Williams G
Diabetes; 1997 Nov; 46(11):1782-5. PubMed ID: 9356026
[TBL] [Abstract][Full Text] [Related]
46. Rationale for the existence of additional adipostatic hormones.
Frühbeck G; Gómez-Ambrosi J
FASEB J; 2001 Sep; 15(11):1996-2006. PubMed ID: 11532980
[TBL] [Abstract][Full Text] [Related]
47. Influence of benzodiazepines on body weight and food intake in obese and lean Zucker rats.
Blasi C
Prog Neuropsychopharmacol Biol Psychiatry; 2000 May; 24(4):561-77. PubMed ID: 10958151
[TBL] [Abstract][Full Text] [Related]
48. Liraglutide, leptin and their combined effects on feeding: additive intake reduction through common intracellular signalling mechanisms.
Kanoski SE; Ong ZY; Fortin SM; Schlessinger ES; Grill HJ
Diabetes Obes Metab; 2015 Mar; 17(3):285-93. PubMed ID: 25475828
[TBL] [Abstract][Full Text] [Related]
49. Leptin actions on food intake and body temperature are mediated by IL-1.
Luheshi GN; Gardner JD; Rushforth DA; Loudon AS; Rothwell NJ
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):7047-52. PubMed ID: 10359836
[TBL] [Abstract][Full Text] [Related]
50. Leptin receptor-deficient obese Zucker rats reduce their food intake in response to a systemic supply of calories from glucose.
Gilbert M; Magnan C; Turban S; André J; Guerre-Millo M
Diabetes; 2003 Feb; 52(2):277-82. PubMed ID: 12540597
[TBL] [Abstract][Full Text] [Related]
51. Decreased plasma leptin levels in lean and obese Zucker rats after treatment with the serotonin reuptake inhibitor fluoxetine.
Dryden S; Brown M; King P; Williams G
Horm Metab Res; 1999 Jun; 31(6):363-6. PubMed ID: 10437624
[TBL] [Abstract][Full Text] [Related]
52. Insulin and leptin combine additively to reduce food intake and body weight in rats.
Air EL; Benoit SC; Clegg DJ; Seeley RJ; Woods SC
Endocrinology; 2002 Jun; 143(6):2449-52. PubMed ID: 12021212
[TBL] [Abstract][Full Text] [Related]
53. Selective resistance to central neural administration of leptin in agouti obese mice.
Rahmouni K; Haynes WG; Morgan DA; Mark AL
Hypertension; 2002 Feb; 39(2 Pt 2):486-90. PubMed ID: 11882595
[TBL] [Abstract][Full Text] [Related]
54. Metabolic responses to intracerebroventricular leptin and restricted feeding.
Wang T; Hartzell DL; Rose BS; Flatt WP; Hulsey MG; Menon NK; Makula RA; Baile CA
Physiol Behav; 1999 Jan 1-15; 65(4-5):839-48. PubMed ID: 10073490
[TBL] [Abstract][Full Text] [Related]
55. Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity.
Davis LM; Michaelides M; Cheskin LJ; Moran TH; Aja S; Watkins PA; Pei Z; Contoreggi C; McCullough K; Hope B; Wang GJ; Volkow ND; Thanos PK
Neuroendocrinology; 2009; 89(2):152-62. PubMed ID: 18984941
[TBL] [Abstract][Full Text] [Related]
56. Cobalt-protoporphyrin suppresses expression of genetic obesity in homozygous (fa/fa) Zucker rats.
Galbraith RA; Kappas A
Pharmacology; 1990; 41(5):292-8. PubMed ID: 2092333
[TBL] [Abstract][Full Text] [Related]
57. Leptin does not fully account for the satiety activity of adipose tissue-conditioned medium.
Weigle DS; Hutson AM; Kramer JM; Fallon MG; Lehner JM; Lok S; Kuijper JL
Am J Physiol; 1998 Oct; 275(4):R976-85. PubMed ID: 9756525
[TBL] [Abstract][Full Text] [Related]
58. Weight loss and hypophagia after high-dose AT1-blockade is only observed after high dosing and depends on regular leptin signalling but not blood pressure.
Müller-Fielitz H; Markert A; Wittmershaus C; Pahlke F; Jöhren O; Raasch W
Naunyn Schmiedebergs Arch Pharmacol; 2011 Apr; 383(4):373-84. PubMed ID: 21287150
[TBL] [Abstract][Full Text] [Related]
59. Central, as well as peripheral naloxone administration suppresses feeding in food-deprived Sprague-Dawley and genetically obese (Zucker) rats.
Thornhill JA; Taylor B; Marshall W; Parent K
Physiol Behav; 1982 Nov; 29(5):841-6. PubMed ID: 7156223
[TBL] [Abstract][Full Text] [Related]
60. Effects of leptin and cholecystokinin in rats with a null mutation of the leptin receptor Lepr(fak).
Wildman HF; Chua S; Leibel RL; Smith GP
Am J Physiol Regul Integr Comp Physiol; 2000 Jun; 278(6):R1518-23. PubMed ID: 10848519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
